Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The association of low ferritin levels with enhanced renal function preservation was more pronounced in postmenopausal women, individuals with vitamin D ≥ 30 ng/ml, and patients with diabetes.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This retrospective cohort study utilized the TriNetX database to evaluate 5-year clinical outcomes in adult women with stage 3 chronic kidney disease (CKD), normal hemoglobin levels (≥12 g/dL), normal mean corpuscular volume (MCV, 80 to 100 fL), and varying serum ferritin concentrations.

Source: Abstract.

Patients were stratified into two groups based on ferritin levels: <100 ng/ml (low ferritin) and 100 to 700 ng/ml (adequate ferritin).

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Prognostic implications of serum ferritin levels in non-anemic women with stage 3 chronic kidney disease

Cohort study · Frontiers in Nutrition · 2025

Original publication title

Prognostic implications of serum ferritin levels in non-anemic women with stage 3 chronic kidney disease

Min-Tser Liao; Chien-Lin Lu; Yi-Chou Hou; Joshua Wang; Kuo-Wang Tsai; Li-Jane Shih; Chia-Chao Wu; Yi-Chun Wang; Kuo-Cheng Lu

Copyright © 2025 Liao, Lu, Hou, Wang, Tsai, Shih, Wu, Wang and Lu.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study of non-anemic female patients with stage 3 CKD found that adequate ferritin levels correlated with a heightened risk of AKI, renal disease progression, and pneumonia. In contrast, low ferritin levels were associated with a higher fracture risk but a lower likelihood of renal function deterioration.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Chronic kidney disease (CKD) is often accompanied by iron deficiency and persistent inflammation, both of which complicate the evaluation of iron metabolism and its clinical relevance. Although serum ferritin is commonly used to assess iron status in anemic CKD patients, data on its prognostic value in non-anemic, iron-deficient individuals remain limited and inconclusive.

Source: Introduction

Abstract: What methods does the paper describe?

This retrospective cohort study utilized the TriNetX database to evaluate 5-year clinical outcomes in adult women with stage 3 chronic kidney disease (CKD), normal hemoglobin levels (≥12 g/dL), normal mean corpuscular volume (MCV, 80 to 100 fL), and varying serum ferritin concentrations. Patients were stratified into two groups based on ferritin levels: <100 ng/ml (low ferritin) and 100 to 700 ng/ml (adequate ferritin). Primary outcomes included all-cause mortality, major adverse cardiovascular events (MACE), acute kidney injury (AKI), pneumonia, fractures, and progression to advanced CKD (estimated glomerular filtration rate < 30 ml/min/1.73 m2).

Source: Methods

Abstract: Results

A total of 66,768 eligible non-anemic women with stage 3 CKD, low serum ferritin levels, and normal MCV were identified. Propensity score matching (1,1) based on demographic variables was performed prior to comparing outcomes between low ferritin (n = 52,295) and adequate ferritin (n = 52,295) cohorts. Over 5 years, low ferritin: relative to adequate ferritin: was associated with significantly lower hazards of AKI, CKD progression, and pneumonia (HRs 0.909, 0.953, and 0.956; log-rank p < 0.05, <0.01, and <0.005, respectively).

By contrast, low ferritin: relative to adequate ferritin: was associated with a significantly higher fracture hazard (HR 1.125; log-rank p < 0.05). No significant differences were observed in all-cause mortality or MACE. Low ferritin was associated with lower all-cause mortality at years 1 to 3 (ORs: 0.739, p < 0.001; 0.842, p < 0.05; 0.895, p = 0.038) and to a lower cumulative incidence of CKD progression at years 2 to 5 (ORs: 0.888 at year 2, 0.898 at year 3, 0.907 at year 4, 0.914 at year 5; all p < 0.05).

Subgroup analysis revealed that low ferritin levels were especially protective against AKI and pneumonia in patients with elevated CRP (>10 mg/L), postmenopausal women, and those aged 18 to 64. The association of low ferritin levels with enhanced renal function preservation was more pronounced in postmenopausal women, individuals with vitamin D ≥ 30 ng/ml, and patients with diabetes. Conversely, adequate ferritin was associated witha lower fracture risk in older adults (>65 years) and those with vitamin D < 20 ng/ml.

Source: Results

Abstract: Conclusion

This study of non-anemic female patients with stage 3 CKD found that adequate ferritin levels correlated with a heightened risk of AKI, renal disease progression, and pneumonia. In contrast, low ferritin levels were associated with a higher fracture risk but a lower likelihood of renal function deterioration.

Source: Conclusion
Authors’ abstract

Introduction

Chronic kidney disease (CKD) is often accompanied by iron deficiency and persistent inflammation, both of which complicate the evaluation of iron metabolism and its clinical relevance. Although serum ferritin is commonly used to assess iron status in anemic CKD patients, data on its prognostic value in non-anemic, iron-deficient individuals remain limited and inconclusive.

Methods

This retrospective cohort study utilized the TriNetX database to evaluate 5-year clinical outcomes in adult women with stage 3 chronic kidney disease (CKD), normal hemoglobin levels (≥12 g/dL), normal mean corpuscular volume (MCV, 80 to 100 fL), and varying serum ferritin concentrations. Patients were stratified into two groups based on ferritin levels: <100 ng/ml (low ferritin) and 100 to 700 ng/ml (adequate ferritin). Primary outcomes included all-cause mortality, major adverse cardiovascular events (MACE), acute kidney injury (AKI), pneumonia, fractures, and progression to advanced CKD (estimated glomerular filtration rate < 30 ml/min/1.73 m2).

Results

A total of 66,768 eligible non-anemic women with stage 3 CKD, low serum ferritin levels, and normal MCV were identified. Propensity score matching (1,1) based on demographic variables was performed prior to comparing outcomes between low ferritin (n = 52,295) and adequate ferritin (n = 52,295) cohorts. Over 5 years, low ferritin: relative to adequate ferritin: was associated with significantly lower hazards of AKI, CKD progression, and pneumonia (HRs 0.909, 0.953, and 0.956; log-rank p < 0.05, <0.01, and <0.005, respectively).

By contrast, low ferritin: relative to adequate ferritin: was associated with a significantly higher fracture hazard (HR 1.125; log-rank p < 0.05). No significant differences were observed in all-cause mortality or MACE. Low ferritin was associated with lower all-cause mortality at years 1 to 3 (ORs: 0.739, p < 0.001; 0.842, p < 0.05; 0.895, p = 0.038) and to a lower cumulative incidence of CKD progression at years 2 to 5 (ORs: 0.888 at year 2, 0.898 at year 3, 0.907 at year 4, 0.914 at year 5; all p < 0.05).

Subgroup analysis revealed that low ferritin levels were especially protective against AKI and pneumonia in patients with elevated CRP (>10 mg/L), postmenopausal women, and those aged 18 to 64. The association of low ferritin levels with enhanced renal function preservation was more pronounced in postmenopausal women, individuals with vitamin D ≥ 30 ng/ml, and patients with diabetes. Conversely, adequate ferritin was associated witha lower fracture risk in older adults (>65 years) and those with vitamin D < 20 ng/ml.

Conclusion

This study of non-anemic female patients with stage 3 CKD found that adequate ferritin levels correlated with a heightened risk of AKI, renal disease progression, and pneumonia. In contrast, low ferritin levels were associated with a higher fracture risk but a lower likelihood of renal function deterioration.

Publication and source details

Original title: Prognostic implications of serum ferritin levels in non-anemic women with stage 3 chronic kidney disease

Min-Tser Liao; Chien-Lin Lu; Yi-Chou Hou; Joshua Wang; Kuo-Wang Tsai; Li-Jane Shih; Chia-Chao Wu; Yi-Chun Wang; Kuo-Cheng Lu

Frontiers in Nutrition · 2025

* Correspondence: Kuo-Cheng Lu, kuochenglu@gmail.com; tch33730@tzuchi.com.twCopyright © 2025 Liao, Lu, Hou, Wang, Tsai, Shih, Wu, Wang and Lu.2025Liao, Lu, Hou, Wang, Tsai, Shih, Wu, Wang and Luhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Taoyuan Armed Forces General Hospital TYAFGH-A-114003 Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation TCRD-TPE-113-RT-3(1/3)The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by grants from Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation [TCRD-TPE-113-RT-3(1/3)] and Taoyuan Armed Forces General Hospital (TYAFGH-A-114003).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:39:12.762069+00:00

DOI: 10.3389/fnut.2025.1682003 · PMC12723871